Description

5-(1-Ethyl-3-Methyl-1H-Pyrazol-4-Yl)-7-(Trifluoromethyl)-4,5,6,7-Tetrahydropyrazolo[1,5-A]Pyrimidine is a high-purity, advanced pharmaceutical intermediate designed for the synthesis of complex active ingredients. This compound matters because it offers a critical building block for research and development in modern drug discovery, particularly for targeted therapies. It is primarily needed by pharmaceutical R&D laboratories, agrochemical innovators, and fine chemical manufacturers seeking reliable, high-quality intermediates for their proprietary synthesis pathways.

Application

• Pharmaceutical Intermediate: Key building block in the synthesis of novel drug candidates, particularly in oncology and central nervous system (CNS) therapeutic areas.
• Agrochemical Research: Used in the development of new-generation pesticides and herbicides, leveraging its heterocyclic core structure.
• Chemical Biology Probe: Serves as a scaffold or precursor for creating molecular probes to study enzyme function and biological pathways.
• Material Science Research: Potential precursor for specialty chemicals and functional materials due to its unique fused pyrazolo-pyrimidine structure.
• Contract Research & Manufacturing (CRO/CMO): Supplied to organizations specializing in custom synthesis and process development for client projects.

Basic Information

Product Name	5-(1-Ethyl-3-Methyl-1H-Pyrazol-4-Yl)-7-(Trifluoromethyl)-4,5,6,7-Tetrahydropyrazolo[1,5-A]Pyrimidine
CAS No.	1006342-77-3
Molecular Formula	C13H16F3N5
Molecular Weight	299.30 g/mol
Synonyms	5-(1-Ethyl-3-methylpyrazol-4-yl)-7-(trifluoromethyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine; 4,5,6,7-Tetrahydropyrazolo[1,5-a]pyrimidine, 5-(1-ethyl-3-methyl-1H-pyrazol-4-yl)-7-(trifluoromethyl)-; 1006342-77-3; 5-(1-Ethyl-3-methyl-1H-pyrazol-4-yl)-7-(trifluoromethyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine; Pyrazolo[1,5-a]pyrimidine intermediate; Fused pyrazole-pyrimidine derivative
EINECS	Contact for details

Quality Control

Our 5-(1-Ethyl-3-Methyl-1H-Pyrazol-4-Yl)-7-(Trifluoromethyl)-4,5,6,7-Tetrahydropyrazolo[1,5-A]Pyrimidine is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and NMR for structural confirmation, to ensure it meets the high standards required for pharmaceutical R&D. Certificates of Analysis (COA) with detailed chromatographic data are provided for every shipment, ensuring full traceability and compliance with your internal quality protocols.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (15-25°C). This compound is moisture-sensitive (hygroscopic); keep the container tightly sealed under an inert atmosphere if possible to maintain stability and prevent degradation.

Specification

Item	Specification
Appearance	White to off-white solid
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 97.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Single Unknown Impurity (HPLC)	≤ 1.0%
Total Impurities (HPLC)	≤ 3.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.